Kite Pharma, Inc. Deferred Tax Assets, Net of Valuation Allowance, Current
Kite Pharma, Inc. had Deferred Tax Assets, Net of Valuation Allowance, Current of $61.00 thousand as of 2014-12-31, per its 10-K filed 2016-02-29.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxAssetsNetCurrent · last filed 2016-02-29
- 2014-12-31: Deferred Tax Assets, Net of Valuation Allowance, Current $61.00K.
| Period end | Deferred Tax Assets, Net of Valuation Allowance, Current |
|---|---|
| 2014-12-31 | $61.00K 10-K · filed 2016-02-29 |